Consolidated Statements of Changes in Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Total Stockholders’ equity	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Operating Partnership Unitholders’ Non-controlling Interests	Operating Partnership unitholders' noncontrolling interests
Beginning balance at Dec. 31, 2022	$ 283,711	$ 229,231	$ 195	$ 254,107	$ 7,486	$ (32,557)	$ 54,480
Beginning balance (in shares) at Dec. 31, 2022			19,555,272
Net proceeds from sale of common stock (in shares)			55,082
Net proceeds from sale of common stock	710	710	$ 1	709
Shares issued upon redemption of OP units (in shares)			22,798
Shares issued upon redemption of operating partnership units	0	409		409			(409)
Issuance and amortization of equity-based compensation (in shares)			146,627
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	1,945	1,377	$ 1	1,376			568
Issuance and amortization under ESPP (in shares)			6,446
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition	94	94		94
Restricted stock withholdings (in shares)			(21,310)
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation	327	327		327
Dividends and distributions	(5,963)	(4,787)				(4,787)	(1,176)
Unrealized loss on derivative instruments	(2,837)	(2,279)			(2,279)		(558)
Net income	433	348				348	85
Reallocation of non-controlling interest	0	(2,338)		(2,338)			2,338
Ending balance (in shares) at Mar. 31, 2023			19,764,915
Ending balance at Mar. 31, 2023	277,766	222,438	$ 197	254,030	5,207	(36,996)	55,328
Beginning balance at Dec. 31, 2023	301,625	243,562	$ 219	287,268	4,621	(48,546)	58,063
Beginning balance (in shares) at Dec. 31, 2023			21,960,211
Net proceeds from sale of common stock (in shares)			576,087
Net proceeds from sale of common stock	7,867	7,867	$ 6	7,861
Issuance of operating partnership units in connection with acquisition transactions	5,788							$ 5,788
Issuance and amortization of equity-based compensation (in shares)			120,941
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition	2,113	1,148	$ 1	1,147			965
Issuance and amortization under ESPP (in shares)			5,137
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition	77	77		77
Restricted stock withholdings (in shares)			(27,919)
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation	396	396		396
Dividends and distributions	(6,859)	(5,520)				(5,520)	(1,339)
Unrealized loss on derivative instruments	2,819	2,267			2,267		552
Net income	256	206				206	50
Reallocation of non-controlling interest	0	(1,079)		(1,079)			1,079
Ending balance (in shares) at Mar. 31, 2024			22,634,457
Ending balance at Mar. 31, 2024	$ 313,290	$ 248,132	$ 226	$ 294,878	$ 6,888	$ (53,860)	$ 65,158